Investment Firm Eminence Capital Sees Mixed Results in Q3 and Q4 of 2022

Eminence Capital, LP, a renowned investment management firm, recently released its 13F filings for Q3 and Q4 of 2022. The data shows that the firm made some significant changes in its holdings, with some companies seeing an increase in shares while others experienced a decrease. Let's delve deeper into the report to understand the performance of the companies in which the fund invested.

The data analysis shows that Ashland Inc (ASH) retained its position as the top holding of Eminence Capital in both quarters, with 4,083,978 shares held over each. The value of the shares increased by 13.2% from $387,855,000 in Q3 to $439,150,000 in Q4. Similarly, Ferguson plc New (FERG) saw a boost in its number of shares held by Eminence Capital, which increased from 1,395,697 in Q3 to 1,384,520 in Q4, a modest decrease of 22.4% in the Q3-Q4 period.

On the other hand, Uber Technologies Inc (UBER) seemed to be less fortunate, with Eminence Capital decreasing its holdings by 20.6%, from 7,994,536 shares in Q3 to 6,357,313 in Q4. Uber's Q3-Q4 values also dive-bombed from $211,855,000 to $157,216,000, an alarming 25.8% decrease in value.

Eminence Capital also reduced its holdings in Electronic Arts Inc (EA) by 21.7%, shedding its shares from 817,204 in Q3 to 606,335 in Q4. Likewise, Pinterest Inc (PINS) saw a 33.5% increase in the number of shares held, from 3,422,610 in Q3 to 4,384,817 in Q4, with a 33.5% increase in quarterly value from $79,747,000 to $106,463,000.

Another key performer for Eminence Capital is Tandem Diabetes Care Inc (TNDM), which saw a staggering 64.4% increase in the number of shares held by the investment firm, from 1,590,787 in Q3 to 2,783,473 in Q4. The value of the shares increased from $76,119,000 in the third quarter to $125,117,000 in Q4, representing growth of 64.4%.

Overall, the data shows that Eminence Capital had mixed results for Q3 and Q4 of 2022 with some stocks increasing while others fell. However, the report shows a few winners like Tandem Diabetes Care and Ashland Inc, which are likely to boost the portfolio's growth.